Literature DB >> 3908485

Effect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia.

Z Chap, T Ishida, J Chou, C J Hartley, R M Lewis, M Entman, J B Field.   

Abstract

Effects of alterations in metabolic clearance rates, hepatic extraction, and plasma concentrations of insulin on hepatic and peripheral contribution to hypoglycemia and glucose counterregulation were studied in conscious dogs. Since insulin and sulfated insulin had markedly different metabolic clearance rates (34 +/- 1 vs. 16 +/- 1 ml/kg per min, respectively) and fractional hepatic extraction (42 +/- 1% vs. 15 +/- 2%, respectively), biologically equivalent amounts infused intraportally produced twofold higher hepatic vein and artery sulphated insulin concentrations and concentrations that were 30% higher in the portal vein. This significantly larger arterial/portal concentration ratio (0.67 vs. 0.45, respectively) permitted assessment of differential distribution of insulin on glucose turnover using [3-3H]glucose. Insulin and sulfated insulin (1 and 2 mU/kg per min) caused similar hypoglycemia. While insulin transiently suppressed glucose production and increased glucose disappearance, sulfated insulin had significantly greater effects on glucose disappearance and clearance, without suppression of glucose production. Despite similar hypoglycemia, sulfated insulin caused greater increment in glucagon. 3 mU/kg per min insulin caused more rapid and greater hypoglycemia, greater glucose clearance, and greater glucagon increments without suppression of glucose production, which indicates that with larger doses of insulin counterregulation can absolutely mask the suppressive effect of insulin. The effects of insulin and sulfated insulin were evaluated using euglycemic clamp to eliminate interference from stimulated counterregulation. Sequential infusion of 1 and 2 mU/kg per min of both insulins suppressed endogenous glucose production to 0 at 150 min, which indicates that the apparent lack of a hepatic effect of sulfated insulin during hypoglycemia was masked by greater counterregulation. This greater counterregulation may reflect greater peripheral glucose clearance, and prevented greater hypoglycemia than after the same insulin doses. The results indicate that the different rates of removal and the total metabolic clearance rate caused different concentrations and relative distribution between the portal and arterial blood compartments, leading to the significantly different contributions by the liver and peripheral tissues to the same hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908485      PMCID: PMC424345          DOI: 10.1172/JCI112231

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Influences of glucose loading and of injected insulin on hepatic glucose output.

Authors:  R STEELE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

2.  Insulin stimulation of amino acid transport in isolated rat hepatocytes is independent of hormone internalization.

Authors:  A LeCam; F Maxfield; M Willingham; I Pastan
Journal:  Biochem Biophys Res Commun       Date:  1979-06-13       Impact factor: 3.575

3.  Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone.

Authors:  C R Kahn; I D Goldfine; D M Neville; P De Meyts
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

4.  Adrenergic mechanisms in recovery from hypoglycemia in man: adrenergic blockade.

Authors:  W L Clarke; J V Santiago; L Thomas; E Ben-Galim; M W Haymond; P E Cryer
Journal:  Am J Physiol       Date:  1979-02

5.  Synchronized pulsed Doppler blood flow and ultrasonic dimension measurement in conscious dogs.

Authors:  C J Hartley; H G Hanley; R M Lewis; J S Cole
Journal:  Ultrasound Med Biol       Date:  1978       Impact factor: 2.998

6.  Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.

Authors:  R A Rizza; P E Cryer; J E Gerich
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.

Authors:  N Eigler; L Saccà; R S Sherwin
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

8.  The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.

Authors:  A D Cherrington; J L Chiasson; J E Liljenquist; A S Jennings; U Keller; W W Lacy
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

10.  Counterregulatory hormonal responses to rapid glucose lowering in diabetic man.

Authors:  U Lilavivathana; R G Brodows; P D Woolf; R G Campbell
Journal:  Diabetes       Date:  1979-10       Impact factor: 9.461

View more
  2 in total

1.  Design and in vivo evaluation of an oral delivery system for insulin.

Authors:  M K Marschütz; P Caliceti; A Bernkop-Schnürch
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  A computer model simulating human glucose absorption and metabolism in health and metabolic disease states.

Authors:  Richard J Naftalin
Journal:  F1000Res       Date:  2016-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.